ArticleCase reports in psychiatry2026
Seronegative Autoimmune Encephalitis Presenting With Severe Neuropsychiatric Symptoms in an Older Adult: A Case of Diagnostic Complexity.
Article in Case reports in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seronegative Autoimmune Encephalitis Presenting With Severe Neuropsychiatric Symptoms in an Older Adult: A Case of Diagnostic Complexity.Case reports in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis (AE) represents a potentially reversible cause of subacute cognitive and psychiatric decline. When no autoantibodies are detected, seronegative AE remains diagnostically challenging, particularly among older adults presenting with new-onset neuropsychiatric symptoms. This report describes an older adult with recurrent episodes of confusion, aphasia, and psychosis whose diagnostic studies-including magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analysis-were unremarkable. The individual had previously demonstrated substantial improvement after corticosteroid therapy and was again treated empirically with immunotherapy following psychiatric consultation. This case highlights the importance of maintaining a high index of suspicion for AE when standard serologic markers are absent and underscores the collaborative role of psychiatry and neurology in evaluating rapidly progressive cognitive and behavioral syndromes, which may present initially as primary psychiatric illness. Early consideration of autoimmune etiologies and prompt initiation of immunotherapy can significantly improve outcomes in patients with otherwise unexplained, rapidly progressive cognitive or behavioral syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.